U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT06972576) titled 'Clinical Study of Combined EphA2-targeted CAR-DC and CAR-T Cell Therapy for Non-small Cell Lung Cancer' on May 07.
Brief Summary: This is an open-label, single-arm clinical study designed to evaluate the safety and preliminary efficacy of EphA2-targeted CAR-DC combined with CAR-T cell therapy in patients with non-small cell lung cancer.
Study Start Date: May 09
Study Type: INTERVENTIONAL
Condition:
Non-Small Cell Lung Cancer
Intervention:
BIOLOGICAL: EphA2-targeted CAR-T Cells
Autologous T cells genetically modified to express a chimeric antigen receptor (CAR) targeting EphA2
BIOLOGICAL: EphA2-targeted CAR-DCs
Autologous den...